CAAS Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-263,172
Closed -$818K 805
2021
Q3
$818K Buy
+263,172
New +$818K 0.02% 271